OBJECTIVE: To explore whether HIV serostatus (HIV-1, HIV-2, and dual (HIV-D) reactivity) and CD4 cell count affect human papillomavirus (HPV) in two groups of women from Côte d'Ivoire. METHODS: We conducted a cross sectional study of two groups of women. One group had low numbers of lifetime sex partners (maternal women, n = 258) and were enrolled based on HIV serostatus. The other group had high numbers of sex partners (female sex workers, n = 278) and all consenting self identified sex workers were admitted to this study. We collected epidemiological and clinical data, and cervicovaginal lavage for HPV testing. RESULTS: The groups had different distributions of HIV seroreactivity, but the rates of HPV DNA detection were similar. Most of the HPV DNAs detected in both groups were high risk types. A strong association of high risk HPV DNA and HIV-1 seropositivity was found in both maternal women (adjusted odds ratio (OR) 7.5 (95% CI 3.2-17.4)) and in sex workers (OR 5.0 (2.1-12.0)). The maternal group also showed an association of high risk HPV DNA detection with HIV-2 (OR 3.7 (1.6-8.5)) and HIV-D (OR 12.7 (4.3-37.5)) that was not observed in the sex workers. In addition, the association of high risk HPV DNA with HIV-1 in the maternal group was independent of low CD4 cell count, while in the sex workers the association depended on CD4 cell counts < or = 500 x 10(6)/l. CONCLUSIONS: We found that an association between HPV and HIV varied depending on the sexual behaviour and CD4 cell count of the population examined.
OBJECTIVE: To explore whether HIV serostatus (HIV-1, HIV-2, and dual (HIV-D) reactivity) and CD4 cell count affect human papillomavirus (HPV) in two groups of women from Côte d'Ivoire. METHODS: We conducted a cross sectional study of two groups of women. One group had low numbers of lifetime sex partners (maternal women, n = 258) and were enrolled based on HIV serostatus. The other group had high numbers of sex partners (female sex workers, n = 278) and all consenting self identified sex workers were admitted to this study. We collected epidemiological and clinical data, and cervicovaginal lavage for HPV testing. RESULTS: The groups had different distributions of HIV seroreactivity, but the rates of HPV DNA detection were similar. Most of the HPV DNAs detected in both groups were high risk types. A strong association of high risk HPV DNA and HIV-1 seropositivity was found in both maternal women (adjusted odds ratio (OR) 7.5 (95% CI 3.2-17.4)) and in sex workers (OR 5.0 (2.1-12.0)). The maternal group also showed an association of high risk HPV DNA detection with HIV-2 (OR 3.7 (1.6-8.5)) and HIV-D (OR 12.7 (4.3-37.5)) that was not observed in the sex workers. In addition, the association of high risk HPV DNA with HIV-1 in the maternal group was independent of low CD4 cell count, while in the sex workers the association depended on CD4 cell counts < or = 500 x 10(6)/l. CONCLUSIONS: We found that an association between HPV and HIV varied depending on the sexual behaviour and CD4 cell count of the population examined.
Authors: S D Vernon; E R Unger; M A Piper; S T Severin; S Z Wiktor; P D Ghys; D L Miller; I R Horowitz; A E Greenberg; W C Reeves Journal: Sex Transm Infect Date: 1999-08 Impact factor: 3.519
Authors: K M De Cock; A Porter; J Kouadio; M Maran; E Gnaore; G Adjorlolo; M F Lafontaine; G Bretton; G M Damet; K Odehouri Journal: AIDS Date: 1990-09 Impact factor: 4.177
Authors: A R Feingold; S H Vermund; R D Burk; K F Kelley; L K Schrager; K Schreiber; G Munk; G H Friedland; R S Klein Journal: J Acquir Immune Defic Syndr (1988) Date: 1990
Authors: E I Svare; S K Kjaer; A M Worm; A Osterlind; H Moi; R B Christensen; C J Meijer; J M Walboomers; A J van den Brule Journal: Int J Cancer Date: 1998-01-05 Impact factor: 7.396
Authors: M Laga; J P Icenogle; R Marsella; A T Manoka; N Nzila; R W Ryder; S H Vermund; W L Heyward; A Nelson; W C Reeves Journal: Int J Cancer Date: 1992-01-02 Impact factor: 7.396
Authors: J ter Meulen; H C Eberhardt; J Luande; H N Mgaya; J Chang-Claude; H Mtiro; M Mhina; P Kashaija; S Ockert; X Yu Journal: Int J Cancer Date: 1992-06-19 Impact factor: 7.396
Authors: J K Kreiss; N B Kiviat; F A Plummer; P L Roberts; P Waiyaki; E Ngugi; K K Holmes Journal: Sex Transm Dis Date: 1992 Jan-Feb Impact factor: 2.830
Authors: S D Vernon; E R Unger; M A Piper; S T Severin; S Z Wiktor; P D Ghys; D L Miller; I R Horowitz; A E Greenberg; W C Reeves Journal: Sex Transm Infect Date: 1999-08 Impact factor: 3.519
Authors: P Mayaud; D K Gill; H A Weiss; E Uledi; L Kopwe; J Todd; G ka-Gina; H Grosskurth; R J Hayes; D C Mabey; C J Lacey Journal: Sex Transm Infect Date: 2001-08 Impact factor: 3.519
Authors: Doreen Ramogola-Masire; Cindy M McGrath; Kurt T Barnhart; Harvey M Friedman; Nicola M Zetola Journal: Int J Gynecol Pathol Date: 2011-11 Impact factor: 2.762
Authors: M-N Didelot-Rousseau; N Nagot; V Costes-Martineau; X Vallès; A Ouedraogo; I Konate; H A Weiss; P Van de Perre; P Mayaud; M Segondy Journal: Br J Cancer Date: 2006-07-11 Impact factor: 7.640